subscribeSubscribe
Fagron Group B.V. Receives FDA Warning Letter

Fagron Group B.V. Receives FDA Warning Letter

FDA
29 Jun 2022
Share Share
Lilly axes Verzenio phase 3 in HER2+ early breast cancer

Lilly axes Verzenio phase 3 in HER2+ early breast cancer
F. Kansteiner FIERCEPHARMA
04 Feb 2022
Share Share
Daré Bioscience Initiates Phase 1/2 Study of DARE-VVA1, Intravaginal Tamoxifen

Daré Bioscience Initiates Phase 1/2 Study of DARE-VVA1, Intravaginal Tamoxifen
BIOSPACE
23 Sep 2021
Share Share
Sanofi nets global phase 3 partners for breast cancer hopeful

Sanofi nets global phase 3 partners for breast cancer hopeful
Kyle LaHucik FIERCE BIOTECH
05 Jun 2021
Share Share
Lower dose of oestrogen receptor modulator seems to reduce risk of breast cancer

Lower dose of oestrogen receptor modulator seems to reduce risk of breast cancer
ECANCER
19 Mar 2021
Share Share
Addition Of Tamoxifen To Abemaciclib Improves OS In Metastatic Breast Cancer

Addition Of Tamoxifen To Abemaciclib Improves OS In Metastatic Breast Cancer
ESMO
20 Sep 2020
Share Share
Eugia Pharma`s Generic Tamoxifen Citrate Receives Approval in US

Eugia Pharma`s Generic Tamoxifen Citrate Receives Approval in US
FDA
19 Aug 2020
Share Share
Can fully shutting down the estrogen receptor make difference in breast cancer?

Can fully shutting down the estrogen receptor make difference in breast cancer?
Amber Tong ENDPTS
22 Jul 2020
Share Share
Tamoxifen Citrate Market Expected to Deliver Dynamic Progression until 2028|Cayman Chemical Company, Agvar Chemicals Inc

Tamoxifen Citrate Market Expected to Deliver Dynamic Progression until 2028|Cayman Chemical Company, Agvar Chemicals Inc

SAGAR.T INDUSTRYNEWSINFO
17 Dec 2019
Share Share
Humana sues generic drug makers over alleged price-fixing

Humana sues generic drug makers over alleged price-fixing
P.M FIERCE HEALTHCARE
19 Oct 2019
Share Share